1. Global prevalence of prediabetes;Rooney;Diabetes Care,2023
2. Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial;McGowan;Lancet Diabetes Endocrinol,2024
3. Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention;von Schwartzenberg;Diabetologia,2024
4. Prevention or delay of diabetes and associated comorbidities: Standards of Care in Diabetes—2024;Diabetes Care,2024
5. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS);Sandforth;Lancet Diabetes Endocrinol,2023